X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-09-21 | VCYT | Veracyte, Inc. | Leite John | Global Chief Commercial Off | S - Sale | $40.00 | -4,015 | 124,329 | -3% | -$160,600 | ||||||
2026-09-18 | PSNL | Personalis, Inc. | Moore Stephen Michael | SVP, GC | S - Sale | $16.22 | -2,068 | 90,257 | -2% | -$33,543 | ||||||
2026-09-18 | PSNL | Personalis, Inc. | Chen Richard | Pres, CMO | S - Sale | $16.22 | -3,998 | 169,882 | -2% | -$64,848 | ||||||
2026-09-18 | PSNL | Personalis, Inc. | Hall Christopher M | CEO | S - Sale | $16.22 | -7,459 | 228,527 | -3% | -$120,985 | ||||||
2026-09-18 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $16.22 | -2,931 | 195,902 | -1% | -$47,541 | ||||||
| D | 2026-09-17 | BLLN | Billiontoone, Inc. | Lynch Thomas P. | See Remarks | S - Sale+OE | $110.33 | -35,112 | 700 | -98% | -$3,873,966 | |||||
| M | 2026-09-15 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $351.49 | -9,150 | 257,378 | -3% | -$3,216,145 | |||||
| D | 2026-09-17 | CAI | Caris Life Sciences, Inc. | Brille Brian J | See Remarks | S - Sale+OE | $30.33 | -400,000 | 730,303 | -35% | -$12,132,080 | |||||
2026-09-15 | GH | Guardant Health, Inc. | Chudova Darya | CTO | S - Sale | $178.00 | -7,738 | 70,635 | -10% | -$1,377,364 | ||||||
2026-09-16 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | S - Sale | $175.74 | -6,674 | 7,906 | -46% | -$1,172,886 | ||||||
2026-09-16 | GH | Guardant Health, Inc. | Azar Alex M II | Dir | S - Sale | $175.00 | -826 | 825 | -50% | -$144,550 | ||||||
| D | 2026-09-16 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale+OE | $175.00 | -116 | 11,449 | -1% | -$20,300 | |||||
| M | 2026-09-14 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $341.15 | -102,000 | 2,125,394 | -5% | -$34,797,271 | |||||
| D | 2026-09-14 | BLLN | Billiontoone, Inc. | Atay Oguzhan | COB, CEO | S - Sale+OE | $99.91 | -30,331 | 157,168 | -16% | -$3,030,444 | |||||
| M | 2026-09-14 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale | $33.73 | -6,600 | 58,584 | -10% | -$222,621 | |||||
2026-09-14 | VCYT | Veracyte, Inc. | Holstein Jens | Dir | S - Sale | $40.95 | -5,000 | 27,471 | -15% | -$204,747 | ||||||
2026-09-14 | YDES | Yd Bio Ltd | Shen Ethan Phd | CEO | P - Purchase | $3.85 | +12,700 | 54,379,189 | 0% | +$48,895 | ||||||
| D | 2026-09-11 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $32.02 | -14,518 | 197,181 | -7% | -$464,870 | |||||
2026-09-11 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale | $158.05 | -4,000 | 39,794 | -9% | -$632,193 | ||||||
2026-09-11 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $327.97 | -50,000 | 2,227,394 | -2% | -$16,398,267 | ||||||
2026-09-09 | BLLN | Billiontoone, Inc. | Ten Bosch John Roderick | SVP of Laboratory Operations | S - Sale | $97.54 | -1,416 | 25,051 | -5% | -$138,117 | ||||||
| D | 2026-09-09 | BLLN | Billiontoone, Inc. | Tsao David | CTO | S - Sale+OE | $98.77 | -20,000 | 1,000 | -95% | -$1,975,400 | |||||
2026-09-10 | SERA | Sera Prognostics, Inc. | Anderson Dyaarl Lee Jr. | Chief Commercial Officer | S - Sale | $2.00 | -1,800 | 76,198 | -2% | -$3,600 | ||||||
2026-09-10 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $2.00 | -7,022 | 837,848 | -1% | -$14,044 | ||||||
2026-09-10 | SERA | Sera Prognostics, Inc. | Inglis Tiffany Eul Davis | Chief Medical Officer | S - Sale | $2.00 | -486 | 91,589 | -1% | -$972 | ||||||
2026-09-10 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $2.00 | -2,190 | 159,566 | -1% | -$4,380 | ||||||
| D | 2026-09-09 | FTRE | Fortrea Holdings Inc. | Russell Carrie Elizabeth | Interim CAO | S - Sale+OE | $16.85 | -246 | 2,384 | -9% | -$4,145 | |||||
| D | 2026-09-09 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $16.85 | -3,149 | 86,419 | -4% | -$53,061 | |||||
2026-09-09 | YDES | Yd Bio Ltd | Shen Ethan Phd | CEO | P - Purchase | $3.93 | +3,100 | 54,366,489 | 0% | +$12,183 | ||||||
2026-09-08 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $2.00 | -20,139 | 844,870 | -2% | -$40,278 | ||||||
2026-09-04 | YDES | Yd Bio Ltd | Shen Ethan Phd | CEO | P - Purchase | $3.67 | +18,378 | 54,363,389 | 0% | +$67,447 | ||||||
2026-09-04 | VCYT | Veracyte, Inc. | Febbo Phillip G. | Chief Scientific, Med Officer | S - Sale | $43.05 | -13,110 | 133,048 | -9% | -$564,410 | ||||||
2026-09-04 | VCYT | Veracyte, Inc. | Chambers Rebecca | CFO | S - Sale | $43.10 | -3,652 | 166,025 | -2% | -$157,394 | ||||||
2026-09-04 | VCYT | Veracyte, Inc. | McGuire Annie | EVP, GC | S - Sale | $43.09 | -3,254 | 131,160 | -2% | -$140,212 | ||||||
| DM | 2026-09-03 | CAI | Caris Life Sciences, Inc. | Spetzler David Baxley | Pres | S - Sale+OE | $24.84 | -597,212 | 1,182,871 | -34% | -$14,834,107 | |||||
| M | 2026-09-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $325.88 | -18,160 | 110,859 | -14% | -$5,917,907 | |||||
2026-09-01 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $320.99 | -1,698 | 98,199 | -2% | -$545,041 | ||||||
2026-09-02 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $19.66 | -1,673 | 986,117 | 0% | -$32,885 | ||||||
2026-09-02 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $19.66 | -2,127 | 580,740 | 0% | -$41,809 | ||||||
2026-09-01 | DGX | Quest Diagnostics Inc | Davis J. E. | CEO, Pres | S - Sale | $242.72 | -10,000 | 122,423 | -8% | -$2,427,200 | ||||||
2026-09-01 | VCYT | Veracyte, Inc. | Bhanji Muna | Dir | S - Sale | $42.97 | -1,864 | 42,718 | -4% | -$80,096 | ||||||
| D | 2026-09-01 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale+OE | $33.39 | -4,152 | 86,005 | -5% | -$138,643 | |||||
2026-09-01 | XGN | Exagen Inc. | Black Jeffrey G. | CFO | S - Sale | $7.22 | -20,614 | 324,910 | -6% | -$148,782 | ||||||
2026-08-31 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale | $32.81 | -1,730 | 65,184 | -3% | -$56,761 | ||||||
| D | 2026-08-28 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $33.20 | -18,560 | 203,115 | -8% | -$616,134 | |||||
2026-08-27 | GRAL | Grail, Inc. | Ofman Joshua J. | CEO | S - Sale | $85.02 | -5,000 | 397,271 | -1% | -$425,098 | ||||||
2026-08-27 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $85.01 | -7,900 | 253,083 | -3% | -$671,579 | ||||||
| D | 2026-08-28 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale+OE | $243.11 | -22,677 | 42,337 | -35% | -$5,513,083 | |||||
2026-08-10 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $321.53 | -6,517 | 197,257 | -3% | -$2,095,411 | ||||||
2026-08-27 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $19.91 | -1,193 | 582,867 | 0% | -$23,747 | ||||||
2026-08-27 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $19.91 | -939 | 987,790 | 0% | -$18,691 | ||||||
| D | 2026-08-25 | BLLN | Billiontoone, Inc. | Tsao David | CTO | S - Sale+OE | $100.00 | -10,000 | 1,000 | -91% | -$1,000,000 | |||||
2026-08-25 | BLLN | Billiontoone, Inc. | Ten Bosch John Roderick | SVP of Laboratory Operations | S - Sale | $100.00 | -1,417 | 26,467 | -5% | -$141,700 | ||||||
2026-08-25 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale | $35.04 | -9,050 | 66,914 | -12% | -$317,112 | ||||||
| M | 2026-08-24 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $34.06 | -24,602 | 85,937 | -22% | -$837,865 | |||||
2026-08-21 | GH | Guardant Health, Inc. | Talasaz Amirali | Co-CEO | S - Sale | $169.16 | -37,500 | 37,500 | -50% | -$6,343,384 | ||||||
| D | 2026-08-19 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $18.19 | -4,892 | 82,411 | -6% | -$88,985 | |||||
2026-08-17 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale | $29.59 | -1,730 | 75,964 | -2% | -$51,191 | ||||||
2026-08-17 | ACON | Aclarion, Inc. | Williams Amanda M | Dir | P - Purchase | $2.73 | +5,857 | 25,857 | +29% | +$15,990 | ||||||
| D | 2026-08-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale+OE | $156.45 | -116 | 11,316 | -1% | -$18,148 | |||||
2026-08-14 | CSTL | Castle Biosciences Inc | Stokes Frank | CFO | S - Sale | $29.77 | -24,908 | 35,177 | -41% | -$741,511 | ||||||
| D | 2026-08-14 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $30.02 | -7,232 | 209,247 | -3% | -$217,105 | |||||
2026-08-14 | ACON | Aclarion, Inc. | Gould Gregory A | CFO | P - Purchase | $2.45 | +10,000 | 60,000 | +20% | +$24,500 | ||||||
2026-08-17 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $318.02 | -3,000 | 6,851 | -30% | -$954,060 | ||||||
2026-08-13 | MDXH | Mdxhealth Sa | Mvm Partners, LLC | Dir | P - Purchase | $0.45 | +2,202,643 | 6,903,100 | +47% | +$1,000,000 | ||||||
2026-08-13 | ACON | Aclarion, Inc. | Bond Ryan | Dir | P - Purchase | $2.37 | +21,122 | 76,122 | +38% | +$50,059 | ||||||
2026-08-13 | ACON | Aclarion, Inc. | Wesemann William | Dir | P - Purchase | $2.34 | +2,150 | 23,713 | +10% | +$5,031 | ||||||
2026-08-13 | ACON | Aclarion, Inc. | Neal David K | Dir | P - Purchase | $2.40 | +7,500 | 30,002 | +33% | +$18,000 | ||||||
2026-08-13 | ACON | Aclarion, Inc. | Ness Brent | CEO | P - Purchase | $2.31 | +5,234 | 111,534 | +5% | +$12,091 | ||||||
2026-08-10 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $325.32 | -6,000 | 266,528 | -2% | -$1,951,942 | ||||||
| D | 2026-08-12 | GH | Guardant Health, Inc. | Monroe Terilyn J. | Chief People Officer | S - Sale+OE | $165.12 | -46,300 | 22,979 | -67% | -$7,645,218 | |||||
2026-08-12 | BDSX | Biodesix Inc | Schuler Jack W | Emeritus Director, 10% | P - Purchase | $24.47 | +15,000 | 2,355,810 | +1% | +$366,992 | ||||||
2026-08-10 | BLLN | Billiontoone, Inc. | Ten Bosch John Roderick | SVP of Laboratory Operations | S - Sale | $92.86 | -1,417 | 27,884 | -5% | -$131,583 | ||||||
| D | 2026-08-10 | BLLN | Billiontoone, Inc. | Tsao David | CTO | S - Sale+OE | $92.86 | -10,000 | 1,000 | -91% | -$928,600 | |||||
| M | 2026-08-10 | BDSX | Biodesix Inc | Schuler Jack W | Emeritus Director, 10% | P - Purchase | $24.13 | +27,600 | 2,340,810 | +1% | +$665,940 | |||||
2026-08-11 | LH | Labcorp Holdings Inc. | Schechter Adam H | Pres, CEO | S - Sale | $320.37 | -4,669 | 102,565 | -4% | -$1,495,808 | ||||||
| D | 2026-08-10 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | S - Sale+OE | $169.58 | -63,605 | 65,374 | -49% | -$10,786,111 | |||||
2026-08-07 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $320.90 | -2,000 | 2,277,394 | 0% | -$641,800 | ||||||
2026-08-07 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $315.66 | -9,150 | 272,528 | -3% | -$2,888,325 | ||||||
2026-08-06 | FTRE | Fortrea Holdings Inc. | Thakral Anshul | CEO | S - Sale | $18.12 | -111,857 | 204,940 | -35% | -$2,026,284 | ||||||
| D | 2026-08-05 | BLLN | Billiontoone, Inc. | Atay Oguzhan | COB, CEO | S - Sale+OE | $150.03 | -15,539 | 0 | -100% | -$2,331,352 | |||||
| D | 2026-08-05 | GH | Guardant Health, Inc. | Hidalgo Medina Manuel | Dir | S - Sale+OE | $164.24 | -1,700 | 4,556 | -27% | -$279,202 | |||||
| D | 2026-08-05 | FTRE | Fortrea Holdings Inc. | Thakral Anshul | CEO | S - Sale+OE | $19.16 | -99,869 | 316,797 | -24% | -$1,913,111 | |||||
2025-11-24 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale | $38.39 | -1,301 | 77,694 | -2% | -$49,945 | ||||||
| DM | 2026-08-04 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $31.07 | -39,016 | 215,379 | -15% | -$1,212,230 | |||||
2026-08-05 | CDNA | Caredx, Inc. | Bickerstaff George | Dir | S - Sale | $46.29 | -20,000 | 134,061 | -13% | -$925,700 | ||||||
2026-08-04 | CDNA | Caredx, Inc. | Cournoyer Christine | Dir | S - Sale | $46.94 | -16,000 | 42,943 | -27% | -$750,973 | ||||||
2026-08-05 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $46.26 | -2,688 | 106,075 | -2% | -$124,349 | ||||||
2026-08-04 | CDNA | Caredx, Inc. | Goldberg Michael | Dir | S - Sale | $47.06 | -44,700 | 152,783 | -23% | -$2,103,497 | ||||||
2026-08-04 | LH | Labcorp Holdings Inc. | Summy Amy B. | EVP, CMO | S - Sale | $306.74 | -924 | 6,956 | -12% | -$283,428 | ||||||
| M | 2026-08-03 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $271.74 | -795 | 51,637 | -2% | -$216,030 | |||||
2026-08-03 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $266.40 | -3,076 | 99,897 | -3% | -$819,431 | ||||||
2026-08-03 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $267.99 | -295 | 183,774 | 0% | -$79,057 | ||||||
2026-08-03 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $265.58 | -3,410 | 129,019 | -3% | -$905,627 | ||||||
2026-08-03 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $267.99 | -334 | 170,073 | 0% | -$89,508 | ||||||
2026-08-03 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $267.99 | -731 | 2,279,394 | 0% | -$195,900 | ||||||
2026-08-03 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $267.99 | -109 | 281,678 | 0% | -$29,211 | ||||||
| D | 2026-08-03 | BLLN | Billiontoone, Inc. | Atay Oguzhan | COB, CEO | S - Sale+OE | $137.07 | -45,000 | 162,500 | -22% | -$6,167,960 | |||||
| D | 2026-08-04 | GH | Guardant Health, Inc. | Clark Ian T | Dir | S - Sale+OE | $158.92 | -14,180 | 2,975 | -83% | -$2,253,451 | |||||
2026-08-03 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $29.77 | -8,586 | 110,539 | -7% | -$255,622 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |